Close Menu

Whole-genome sequencing is still very expensive, but it is being used to make a difference in the lives of patients with rare diseases, says Richard Knox at the NPR Shots blog. Clinicians were able to treat Alexis and Noah Beery — 14-year-old twins afflicted with a rare disease called dopa-responsive dystonia — with a simple and effective therapy for their disease after they underwent whole-genome sequencing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.